Caris Life Sciences (CAI) shares rose 33% in their debut Wednesday on Nasdaq following the company's initial public offering of 23.5 million shares priced at $21 each.
The stock traded at $27.86 around midday after opening at $27 and rising as high as $29.40.
The company granted underwriters an option to buy up to an additional 3.53 million shares at the IPO price.
The IPO is expected to close Friday.
Price: 27.86, Change: +6.86, Percent Change: +32.52
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。